Omega Healthcare Investors, Inc. (NYSE:OHI) was downgraded by analysts at Hilliard Lyons to a “buy” rating in a research note issued to investors on Wednesday.

Other equities analysts have also recently issued reports about the company. ValuEngine upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Zacks Investment Research upgraded Omega Healthcare Investors from a “sell” rating to a “buy” rating and set a $35.00 price target on the stock in a report on Wednesday, October 4th. TheStreet cut Omega Healthcare Investors from a “b-” rating to a “c” rating in a report on Monday. Capital One Financial Corporation reiterated an “equal weight” rating on shares of Omega Healthcare Investors in a report on Sunday, October 22nd. Finally, Stifel Nicolaus cut Omega Healthcare Investors from a “buy” rating to a “hold” rating and cut their target price for the stock from $35.00 to $29.00 in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have given a buy rating to the company. Omega Healthcare Investors currently has a consensus rating of “Hold” and a consensus price target of $31.83.

Omega Healthcare Investors (NYSE:OHI) traded up $0.32 during trading on Wednesday, hitting $28.38. The company’s stock had a trading volume of 1,748,648 shares, compared to its average volume of 2,971,450. The stock has a market cap of $5.52 billion, a P/E ratio of 8.20 and a beta of 0.53.

ILLEGAL ACTIVITY NOTICE: “Hilliard Lyons Downgrades Omega Healthcare Investors, Inc. (OHI) to Buy” was published by Watch List News and is owned by of Watch List News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/hilliard-lyons-downgrades-omega-healthcare-investors-inc-ohi-to-buy/1676479.html.

In related news, Director Bernard J. Korman acquired 100,000 shares of the company’s stock in a transaction on Tuesday, October 31st. The shares were acquired at an average cost of $28.24 per share, for a total transaction of $2,824,000.00. Following the purchase, the director now owns 903,895 shares in the company, valued at $25,525,994.80. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Craig R. Callen acquired 10,000 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were bought at an average price of $27.38 per share, for a total transaction of $273,800.00. The disclosure for this purchase can be found here. 1.54% of the stock is owned by company insiders.

Large investors have recently modified their holdings of the business. Ffcm LLC lifted its stake in Omega Healthcare Investors by 197.6% during the 2nd quarter. Ffcm LLC now owns 3,402 shares of the real estate investment trust’s stock valued at $115,000 after acquiring an additional 2,259 shares in the last quarter. Bronfman E.L. Rothschild L.P. lifted its stake in Omega Healthcare Investors by 167.7% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,432 shares of the real estate investment trust’s stock valued at $113,000 after acquiring an additional 2,150 shares in the last quarter. Chicago Partners Investment Group LLC lifted its stake in Omega Healthcare Investors by 656.6% during the 2nd quarter. Chicago Partners Investment Group LLC now owns 6,015 shares of the real estate investment trust’s stock valued at $193,000 after acquiring an additional 5,220 shares in the last quarter. ARP Americas LLC bought a new position in Omega Healthcare Investors during the 2nd quarter valued at $218,000. Finally, Good Life Advisors LLC bought a new position in Omega Healthcare Investors during the 3rd quarter valued at $209,000. Institutional investors and hedge funds own 72.87% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.